Phase II randomized trial of capecitabine with bevacizumab and external beam radiation therapy as preoperative treatment for patients with resectable locally advanced rectal adenocarcinoma: long term results.
Ramón SalazarJaume CapdevilaJose Luis ManzanoCarles PericayMercedes Martínez-VillacampaCarlos LópezFerrán LosaMaría José SafontAuxiliadora Gómez-EspañaVicente Alonso-OrduñaPilar EscuderoJavier GallegoBeatriz García-ParedesAmalia PalaciosSebastiano BiondoCristina GrávalosEnrique Arandanull nullPublished in: BMC cancer (2020)
EudraCT number: 2009-010192-24 . Clinicaltrials.gov number: NCT01043484 .
Keyphrases
- locally advanced
- rectal cancer
- radiation therapy
- phase ii
- neoadjuvant chemotherapy
- squamous cell carcinoma
- phase ii study
- clinical trial
- open label
- patients undergoing
- radiation induced
- phase iii
- replacement therapy
- double blind
- smoking cessation
- study protocol
- monte carlo
- electron microscopy
- metastatic breast cancer